Walgreens stock surged 27% on Friday, Jan 10, after the company reported upbeat Q1 (fiscal ends in August) results.
The long-struggling chain reported better-than-expected revenue for its Q1 2025, although operating losses grew as it plans ...
The pharmacy “allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores,” the Justice Department said.
Walgreens stock (NASDAQ:WBA) surged 27% on Friday, Jan 10, after the company reported upbeat Q1 (fiscal ends in August) results. It reported revenue of $39.5 billion and adjusted earnings of $0.51 ...
Walgreens Boots Alliance surged by >25% today, following strong Q1 2025 earnings and revenue outperformance. Click here to ...
WBA's fiscal 2025 first-quarter results are expected to continue to reflect a soft U.S. Retail Pharmacy performance.
Motorola Solutions delivered a strong performance in 2024, reporting revenue and earnings per share that surpassed consensus ...
Walgreens Boots Alliance has seen a significant decline in stock price. Read why I am reaffirming my Hold rating on WBA ahead ...
Walgreens Boots Alliance, Inc. WBA delivered adjusted earnings per share (EPS) of 51 cents in the first quarter of fiscal ...
Walgreens Boots Alliance (WBA) stands at a pivotal moment as 2025 begins. It is drawing intense investor scrutiny after ...